NCT01177826 - Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children | Biotech Hunter

Enrollment

643

Participants

Timeline

Start Date

February 23, 2008

Primary Completion Date

June 11, 2010

Study Completion Date

June 11, 2010

Conditions

Infections, RotavirusRotavirus Vaccines

Interventions

PROCEDURE

Sample collection

Stool sample

Trial Locations (29)

1020

GSK Investigational Site, Brussels

1050

GSK Investigational Site, Brussels

1070

GSK Investigational Site, Brussels

1180

GSK Investigational Site, Brussels

1340

GSK Investigational Site, Ottignies

1400

GSK Investigational Site, Nivelles

2020

GSK Investigational Site, Antwerp

2100

GSK Investigational Site, Deurne

2170

GSK Investigational Site, Merksem

2610

GSK Investigational Site, Wilrijk

2650

GSK Investigational Site, Edegem

3500

GSK Investigational Site, Hasselt

3550

GSK Investigational Site, Heusden

3600

GSK Investigational Site, Genk

3700

GSK Investigational Site, Tongeren

3800

GSK Investigational Site, Sint-Truiden

5000

GSK Investigational Site, Namur

6041

GSK Investigational Site, Gosselies

6460

GSK Investigational Site, Chimay

7000

GSK Investigational Site, Mons

7301

GSK Investigational Site, Hornu

8400

GSK Investigational Site, Ostend

8500

GSK Investigational Site, Kortrijk

8800

GSK Investigational Site, Roeselaere

8900

GSK Investigational Site, Ieper

9000

GSK Investigational Site, Ghent

9100

GSK Investigational Site, Sint-Niklaas

9800

GSK Investigational Site, Deinze

9900

GSK Investigational Site, Eeklo